ATNM Financial Statements

Balance sheet, income statement, cash flow, and dividends for Actinium Pharmaceuticals Inc (ATNM).


$39.31M Market Cap.

As of 04/01/2025 5:00 PM ET (MRY) • Disclaimer

ATNM Market Cap. (MRY)


ATNM Shares Outstanding (MRY)


ATNM Assets (MRY)


Total Assets

$76.90M

Total Liabilities

$44.14M

Total Investments

$324.00K

ATNM Income (MRY)


Revenue

$0

Net Income

-$38.24M

Operating Expense

$42.12M

ATNM Cash Flow (MRY)


CF Operations

-$33.07M

CF Investing

-$11.00K

CF Financing

$29.32M

ATNM Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

ATNM Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$76,899,000 (-5.58%)

$81,445,000 (-28.68%)

$114,192,000 (42.05%)

$80,388,000 (21.07%)

Assets Current

$74,506,000 (-4.80%)

$78,263,000 (-29.46%)

$110,942,000 (39.11%)

$79,749,000 (22.83%)

Assets Non-Current

$2,393,000 (-24.80%)

$3,182,000 (-2.09%)

$3,250,000 (408.61%)

$639,000 (-56.59%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$32,758,000 (-9.95%)

$36,379,000 (-45.28%)

$66,481,000 (-9.61%)

$73,545,000 (19.94%)

Property Plant & Equipment Net

$2,069,000 (-27.88%)

$2,869,000 (-2.68%)

$2,948,000 (361.35%)

$639,000 (-38.02%)

Cash & Equivalents

$72,904,000 (-4.92%)

$76,677,000 (-29.85%)

$109,306,000 (39.74%)

$78,221,000 (22.22%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$35,000,000 (0.00%)

$35,000,000 (0.00%)

$35,000,000 (3407.01%)

$998,000 (0%)

Total Investments

$324,000 (3.51%)

$313,000 (3.64%)

$302,000 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$324,000 (3.51%)

$313,000 (3.64%)

$302,000 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$7,568,000 (-4.84%)

$7,953,000 (-21.49%)

$10,130,000 (83.02%)

$5,535,000 (27.53%)

Accumulated Retained Earnings (Deficit)

-$375,826,000 (-11.33%)

-$337,583,000 (-16.91%)

-$288,765,000 (-12.91%)

-$255,748,000 (-10.73%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$1,573,000 (-25.56%)

$2,113,000 (-18.13%)

$2,581,000 (732.58%)

$310,000 (-57.99%)

Debt Current

$580,000 (7.21%)

$541,000 (8.63%)

$498,000 (62.21%)

$307,000 (-28.10%)

Debt Non-Current

$993,000 (-36.83%)

$1,572,000 (-24.53%)

$2,083,000 (69333.33%)

$3,000 (-99.04%)

Total Liabilities

$44,141,000 (-2.05%)

$45,066,000 (-5.54%)

$47,711,000 (597.22%)

$6,843,000 (34.76%)

Liabilities Current

$8,148,000 (-4.07%)

$8,494,000 (-20.08%)

$10,628,000 (55.38%)

$6,840,000 (43.49%)

Liabilities Non-Current

$35,993,000 (-1.58%)

$36,572,000 (-1.38%)

$37,083,000 (1236000.00%)

$3,000 (-99.04%)

ATNM Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$81,000 (-92.14%)

$1,030,000 (-9.97%)

$1,144,000 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$12,076,000 (-9.41%)

$13,331,000 (11.10%)

$11,999,000 (48.56%)

$8,077,000 (28.04%)

Research & Development Expense

$30,045,000 (-22.30%)

$38,670,000 (67.15%)

$23,135,000 (28.31%)

$18,031,000 (12.10%)

Operating Expenses

$42,121,000 (-19.00%)

$52,001,000 (48.01%)

$35,134,000 (34.57%)

$26,108,000 (16.59%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$38,243,000 (21.66%)

-$48,818,000 (-47.86%)

-$33,017,000 (-33.27%)

-$24,774,000 (-11.52%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$38,243,000 (21.66%)

-$48,818,000 (-47.86%)

-$33,017,000 (-33.27%)

-$24,774,000 (-11.52%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$38,243,000 (21.66%)

-$48,818,000 (-47.86%)

-$33,017,000 (-33.27%)

-$24,774,000 (-11.51%)

Weighted Average Shares

$30,070,028 (13.03%)

$26,604,045 (10.20%)

$24,141,545 (17.37%)

$20,568,373 (69.51%)

Weighted Average Shares Diluted

$30,070,028 (13.03%)

$26,604,045 (10.20%)

$24,141,545 (17.37%)

$20,568,373 (69.51%)

Earning Before Interest & Taxes (EBIT)

-$38,243,000 (21.66%)

-$48,818,000 (-47.86%)

-$33,017,000 (-33.27%)

-$24,774,000 (-11.52%)

Gross Profit

$0 (0%)

$81,000 (-92.14%)

$1,030,000 (-9.97%)

$1,144,000 (0%)

Operating Income

-$42,121,000 (18.87%)

-$51,920,000 (-52.24%)

-$34,104,000 (-36.61%)

-$24,964,000 (-11.48%)

ATNM Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$11,000 (92.81%)

-$153,000 (58.20%)

-$366,000 (-175.19%)

-$133,000 (47.43%)

Net Cash Flow from Financing

$29,321,000 (97.18%)

$14,870,000 (-35.65%)

$23,109,000 (-34.39%)

$35,221,000 (-53.76%)

Net Cash Flow from Operations

-$33,072,000 (30.13%)

-$47,335,000 (-647.61%)

$8,644,000 (141.43%)

-$20,866,000 (3.47%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$3,762,000 (88.47%)

-$32,618,000 (-203.92%)

$31,387,000 (120.69%)

$14,222,000 (-73.81%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$11,000 (92.81%)

-$153,000 (58.20%)

-$366,000 (-175.19%)

-$133,000 (47.43%)

Issuance (Repayment) of Debt Securities

-$9,000 (-125.00%)

-$4,000 (91.84%)

-$49,000 (42.35%)

-$85,000 (81.52%)

Issuance (Purchase) of Equity Shares

$29,330,000 (97.19%)

$14,874,000 (-35.77%)

$23,158,000 (-34.41%)

$35,306,000 (-53.93%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$5,292,000 (37.74%)

$3,842,000 (37.46%)

$2,795,000 (64.99%)

$1,694,000 (35.09%)

Depreciation Amortization & Accretion

$811,000 (2.66%)

$790,000 (13.02%)

$699,000 (33.40%)

$524,000 (17.23%)

ATNM Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

100.00% (0.00%)

100.00% (0.00%)

100.00%

Profit Margin

-

-60269.10% (-1780.18%)

-3205.50% (-48.02%)

-2165.60%

EBITDA Margin

-

-59293.80% (-1789.72%)

-3137.70% (-48.02%)

-2119.80%

Return on Average Equity (ROAE)

-96.40% (6.04%)

-102.60% (-121.12%)

-46.40% (-42.77%)

-32.50% (41.34%)

Return on Average Assets (ROAA)

-45.40% (13.69%)

-52.60% (-70.23%)

-30.90% (-1.31%)

-30.50% (37.76%)

Return on Sales (ROS)

-

-60269.10% (-1780.18%)

-3205.50% (-48.02%)

-2165.60%

Return on Invested Capital (ROIC)

1389.10% (103.94%)

-35247.70% (-1763.80%)

2118.50% (81.56%)

1166.80% (-14.45%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.99 (64.27%)

-2.78 (64.29%)

-7.77 (-55.23%)

-5.01 (-17.50%)

Price to Sales Ratio (P/S)

-

1,668.5 (568.42%)

249.62 (131.01%)

108.06

Price to Book Ratio (P/B)

1.2 (-68.65%)

3.83 (-6.22%)

4.08 (126.78%)

1.8 (4.17%)

Debt to Equity Ratio (D/E)

1.35 (8.72%)

1.24 (72.56%)

0.72 (672.04%)

0.09 (12.05%)

Earnings Per Share (EPS)

-1.27 (30.60%)

-1.83 (-33.58%)

-1.37 (-14.17%)

-1.2 (34.43%)

Sales Per Share (SPS)

0 (0%)

0 (-93.02%)

0.04 (-23.21%)

0.06 (0%)

Free Cash Flow Per Share (FCFPS)

-1.1 (38.38%)

-1.78 (-620.41%)

0.34 (133.59%)

-1.02 (43.34%)

Book Value Per Share (BVPS)

1.09 (-20.34%)

1.37 (-50.36%)

2.75 (-22.99%)

3.58 (-29.23%)

Tangible Assets Book Value Per Share (TABVPS)

2.56 (-16.47%)

3.06 (-35.29%)

4.73 (21.03%)

3.91 (-28.58%)

Enterprise Value Over EBIT (EV/EBIT)

1 (200.00%)

-1 (80.00%)

-5 (-150.00%)

-2 (33.33%)

Enterprise Value Over EBITDA (EV/EBITDA)

1.01 (182.59%)

-1.22 (75.67%)

-5.01 (-141.14%)

-2.08 (22.33%)

Asset Turnover

0 (0%)

0 (-90.00%)

0.01 (-28.57%)

0.01 (0%)

Current Ratio

9.14 (-0.76%)

9.21 (-11.73%)

10.44 (-10.46%)

11.66 (-14.40%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$33,083,000 (30.33%)

-$47,488,000 (-673.67%)

$8,278,000 (139.42%)

-$20,999,000 (3.98%)

Enterprise Value (EV)

-$37,642,177 (-164.35%)

$58,493,280 (-63.85%)

$161,789,209 (221.30%)

$50,354,336 (-13.45%)

Earnings Before Tax (EBT)

-$38,243,000 (21.66%)

-$48,818,000 (-47.86%)

-$33,017,000 (-33.27%)

-$24,774,000 (-11.52%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$37,432,000 (22.06%)

-$48,028,000 (-48.61%)

-$32,318,000 (-33.27%)

-$24,250,000 (-11.40%)

Invested Capital

-$2,580,000 (-59.95%)

-$1,613,000 (48.97%)

-$3,161,000 (27.55%)

-$4,363,000 (-167.50%)

Working Capital

$66,358,000 (-4.89%)

$69,769,000 (-30.45%)

$100,314,000 (37.59%)

$72,909,000 (21.20%)

Tangible Asset Value

$76,899,000 (-5.58%)

$81,445,000 (-28.68%)

$114,192,000 (42.05%)

$80,388,000 (21.07%)

Market Capitalization

$39,306,823 (-71.77%)

$139,260,280 (-48.69%)

$271,397,209 (104.97%)

$132,405,336 (24.94%)

Average Equity

$39,664,500 (-16.60%)

$47,561,750 (-33.19%)

$71,188,500 (-6.66%)

$76,266,250 (90.02%)

Average Assets

$84,306,500 (-9.22%)

$92,866,500 (-13.08%)

$106,842,500 (31.73%)

$81,104,500 (78.99%)

Invested Capital Average

-$2,753,000 (-2087.73%)

$138,500 (108.89%)

-$1,558,500 (26.60%)

-$2,123,250 (-30.36%)

Shares

31,195,891 (13.80%)

27,413,441 (7.57%)

25,483,306 (15.67%)

22,030,838 (62.15%)